SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000891554-02-000040
Filing Date
2002-01-07
Accepted
2002-01-07 00:00:00
Documents
1
Group Members
AVENTIS PHARMACEUTICALS INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D d27626_13d-a.txt SC 13D/A 8971
  Complete submission text file 0000891554-02-000040.txt   10975
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-47221 | Film No.: 2503262
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627
Business Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627 8169665000
HMR PHARMA INC (Filed by) CIK: 0001030157 (see all company filings)

IRS No.: 431769328 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations